Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets

Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets
Fisher & Paykel Healthcare and its managing director Lewis Gradon hit targets for operating revenue, profit and cashflow. (Image: NZME)
Rebecca Stevenson
New Zealand Exchange-listed medical device manufacturer Fisher & Paykel Healthcare says the feedback from US customers on its new solo mask for obstructive sleep apnea has been tremendous. Fisher & Paykel reported its full-year result to March 31 on Wednesday, reporting underlying net profit after tax of $264.4 million after stripping out one-off items including a $98m revaluation of land it purchased at Karaka. Free cashflow rose to $73.8m compared to $12.5m in the previous financial year, while operating revenue wa...

More Markets

Takeover bid is opportunistic and undervalued: THL
Markets

Takeover bid is opportunistic and undervalued: THL

Tourism Holdings' board remains open to engagement with the Consortium.

One man, five boards: The NZ director spiderweb
Markets

One man, five boards: The NZ director spiderweb

James Miller is at the top of the directorship pyramid.

Increased US tariffs drive NZ stocks lower
Markets Market Close

Increased US tariffs drive NZ stocks lower

F&P Healthcare and Ebos shares both dropped over 2% on the tariff news.

Jamie Gray 01 Aug 2025
Journee to succeed Withers as Warehouse chair
Retail

Journee to succeed Withers as Warehouse chair

Journee ensures "strong continuity of leadership", Joan Withers said.

Gregor Thompson 01 Aug 2025